PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsCommentNatural killer cells and fertility: unwarranted treatments flourish amid misinformation and poor regulation

BioNews

Natural killer cells and fertility: unwarranted treatments flourish amid misinformation and poor regulation

Published 9 November 2015 posted in Comment and appears in BioNews 827

Author

Dr Norman Shreeve

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.

In recent years a range of treatments aimed at suppressing uterine natural killer activity have sprung up, but this has no scientific rationale and can have significant and dangerous side effects...

Natural killer (NK) cells are a type of lymphocyte (white blood cell) vital to the body's immune defence system. They are highly important mediators in the fight against bacteria, viruses and other pathogens, and also help control cancer. These cells, which circulate in the blood, were named 'natural killer' because they are able to identify and attack foreign material without the usual recognition system that the major lymphocytes in the body (T lymphocytes) use.

Since Nobel laureate Sir Peter Medawar first postulated the notion in the 1950s (1), investigating how the maternal immune system tolerates and regulates early pregnancy has been a hotly debated topic. In the early 1990s, scientists discovered lymphocytes with some features similar to NK cells in the endometrium, the lining of the uterus (uterine NK, uNK) (2). They were especially abundant at the maternal—fetal interface in early pregnancy, where the placenta invades into the uterine lining (known as decidua in pregnancy). Despite belonging to the natural-killer cell lineage, uNK in fact behave quite differently from their NK counterparts that circulate in the blood. They display none of the innate cytotoxic ability to attack or kill cell lines that blood NK are so adept at (3).

Since their initial discovery, scientists have suggested that the functional importance of these cells is in the essential job of remodelling maternal blood vessels to allow appropriate nourishment of the growing fetus. This is achieved by placental cell invasion of maternal arteries. In other words, they are involved in drawing a boundary between two individuals. Indeed, both experimental animal models and genetic human studies have highlighted that a sufficient degree of activation of uNK cells is necessary in avoiding pregnancy complications related to deficient placental formation, including miscarriage, pre-eclampsia and fetal growth restriction (4).

Unfortunately, the 'killer' label is a complete misnomer and has given rise to an entire industry within assisted reproductive technology (ART), e.g. IVF or ICSI and recurrent miscarriage clinics aimed at targeting these cells. It has now become common practice for these clinics to charge patients significant sums of money for measurements of uNK cells or blood NK (or both). Providers of such tests have invented a rationale in which they claim that raised levels of NK cells leads to the body 'rejecting' or 'attacking' the embryo, resulting in early pregnancy loss. There is absolutely no evidence that this ever occurs. Especially in cases where other causes cannot be identified, blaming pregnancy loss on uNK cells can give frustrated and hopeless couples a much-welcomed reason for their failed attempts at parenthood.

The HFEA, Human Fertilisation and Embryology Authority, is the ART regulatory body in the UK. They license and regularly review all providers in the private and public sectors. Unfortunately, they do not currently regulate adjunctive treatments offered alongside IVF/ICSI cycles. In recent years a range of treatments aimed at suppressing uNK activity have sprung up, including intravenous immunoglobulin, Intralipid, corticosteroids (e.g. prednisolone), anti-tumour necrosis factor, tacrolimus and granulocyte-colony stimulating factor. These medications can have significant and dangerous side effects, and in other conditions their administration is reserved for hospital settings where appropriate medical support exists.

As the exact role of uNK in pregnancy is still unknown, targeting uNK in this way (even if the treatments do actually affect them somehow) has no scientific rationale and is potentially dangerous for the following reasons:

a) there is no universally accepted normal reference range for uNK cell levels or even a protocol for how to count them, therefore results and their interpretation vary widely from clinic to clinic;

b) there is no relationship between blood NK levels and uNK cytotoxicity so testing blood NKs is pointless;

c) there is no good-quality experimental or clinical evidence to support immune suppression as a method for improving pregnancy outcome;

d) many of the treatments offered have significant side effects related to suppressing the body's natural immunity. The maternal immune system is not normally suppressed during pregnancy and uterine NK cells have a physiological role in cooperating with the fetal/placental cells to optimise placentation. This interaction is not a conflict but a compromising dialogue.

So where does this leave the patient? Probably quite confused. In fact, it is actually rather straightforward — there is no evidence to suggest that any currently available measurement of NK cells, be it in peripheral blood or the uterus, can reliably guide treatment of infertility (5). There is also no good evidence for the use of any immune-modulating therapies in recurrent miscarriage (or recurrent implantation failure in ART). Others within the scientific and clinical community have called for such treatments to be confined to research settings only (6). In otherwise healthy young women, it is impossible to see how the risks of taking these drugs could currently outweigh the unproven benefit in pregnancy outcome.

Related Articles

PET BioNews
News
31 August 2017 • 2 minutes read

Fetal immune system is active, not immature

by Cara Foley

The fetal immune system is more mature in the second trimester than previously thought, which could assist research into diseases, miscarriage and immune tolerance, researchers say...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
14 September 2016 • 2 minutes read

Progesterone does not help women with recurrent miscarriages

by Rikita Patel

Progesterone supplementation in the first trimester of pregnancy does not improve outcomes for women with unexplained recurrent miscarriages, according to a large clinical trial...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
18 April 2016 • 3 minutes read

'Widespread incompetence' across the fertility sector, says senior judge

by Dr Antony Starza-Allen

The President of the Family Division, Sir James Munby, has spoken of 'widespread incompetence' in the fertility sector and has questioned the adequacy of the regulatory framework overseen by the Human Fertilisation and Embryology Authority...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
10 March 2016 • 2 minutes read

Lack of stem cells in womb linked to recurrent miscarriage

by Dr Lanay Griessner

Recurrent miscarriage could be caused by a lack of resident stem cells in the lining of the womb, according to a study...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
21 September 2015 • 3 minutes read

HFEA releases 2014 incidents report

by Dr Mary Yarwood

The Human Fertilisation and Embryology Authority has released its second annual report into adverse incidents at fertility clinics in the UK, showing a slight reduction in the overall number of reported problems following fertility treatment...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
19 May 2015 • 5 minutes read

A TripAdvisor for fertility clinics - would you recommend it?

by Dr Nicoletta Charolidi

At this Progress Educational Trust event there was a lively debate about whether and how the HFEA should collect feedback from patients about fertility clinics across the UK and publish it on its website...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
11 November 2013 • 3 minutes read

An inconvenient truth: ICSI is not necessary for the majority of IVF patients

by Dr Steven Fleming

Despite the views of several IVF experts that intra-cytoplasmic sperm injection is overused in IVF, it continues unabated. So why is nobody listening?...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
9 June 2009 • 1 minute read

Two infertility treatments found to be no better than nature

by Alison Cranage

Two common infertility treatments are no more effective than trying to conceive naturally, according to a study published in the British Medical Journal. The study looked at the effectiveness of taking the drug clomifene citrate (CC) or having intra-uterine insemination (IUI) versus no intervention, and found that...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Will organs from GM pigs save our bacon?

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

FILM: 200 Years of Mendel – From Peas to Personalised Medicine

1 August 2022 • 4 minutes read

Women's Health Strategy plans reflect rising needs of same-sex female couples

25 July 2022 • 4 minutes read

Was the Women's Health Strategy worth the wait?

25 July 2022 • 4 minutes read

Why the UK should extend the 14-day rule to 28 days

25 July 2022 • 5 minutes read

200 Years of Mendel: From Peas to Personalised Medicine

15 August 2022 • 5 minutes read

Same-sex parent should not have been forced to adopt child

15 August 2022 • 2 minutes read

FILM: Editing the Human Genome – Where Are We Now? What Happens Next?

8 August 2022 • 4 minutes read

Citizenship and same-sex parents – about time, Sweden!

8 August 2022 • 2 minutes read

FILM: 200 Years of Mendel – From Peas to Personalised Medicine

1 August 2022 • 4 minutes read

Women's Health Strategy plans reflect rising needs of same-sex female couples

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856